Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |